Xavier Matias-Guiu Guia

Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

Modern Pathology 30 277-277. 01/02/2017.

Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

LABORATORY INVESTIGATION 97 277-277. 01/02/2017.

Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D

Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

Autophagy 13 608-624. 05/01/2017.

[doi:10.1080/15548627.2016.1271512]

van der Putten, LJM; van de Vijver, K; Bartosch, C; Davidson, B; Gatius, S; Matias-Guiu, X; McCluggage, WG; Toledo, G; van der Wurff, AAM; Pijnenborg, JMA; Massuger, LFAG; Bulten, J

Reproducibility of measurement of myometrial invasion in endometrial carcinoma

VIRCHOWS ARCHIV 470 63-68. 01/01/2017.

[doi:10.1007/s00428-016-2035-5]

Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X

Endometrial Carcinoma: Specific Targeted Pathways

Advances in Experimental Medicine and Biology 943 149-207. 01/01/2017.

[doi:10.1007/978-3-319-43139-0_6]

Castelblanco, E; Zafon, C; Maravall, J; Gallel, P; Martinez, M; Capel, I; Bella, MR; Halperin, I; Temprana, J; Iglesias, C; Puig-Domingo, M; Robledo, M; Matias-Guiu, X; Mauricio, D

APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions

Thyroid 27 59-66. 01/01/2017.

[doi:10.1089/thy.2016.0094]

Mota, A; Colas, E; Garcia-Sanz, P; Campoy, I; Rojo-Sebastian, A; Gatius, S; Garcia, A; Chiva, L; Alonso, S; Gil-Moreno, A; Gonzalez-Tallada, X; Diaz-Feijoo, B; Vidal, A; Ziober-Malinowska, P; Bobinski, M; Lopez-Lopez, R; Abal, M; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

Modern Pathology 30 134-145. 01/01/2017.

[doi:10.1038/modpathol.2016.143]

Piulats, JM; Matias-Guiu, X

Immunotherapy in Endometrial Cancer: In the Nick of Time

CLINICAL CANCER RESEARCH 22 5623-5625. 01/12/2016.

[doi:10.1158/1078-0432.CCR-16-1820]

Lecube, A; Valladares, S; Lopez-Cano, C; Gutierrez, L; Ciudin, A; Fort, JM; Reñé JM; Matias-Guiu, X; de Torres, I; Bueno, M; Pallares, J; Baena, JA

The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori

PLOS ONE 11 -. 28/11/2016.

[doi:10.1371/journal.pone.0166741]

Rosa-Rosa, JM; Leskela, S; Cristobal-Lana, E; Santon, A; Lopez-Garcia, MA; Muñoz G; Perez-Mies, B; Biscuola, M; Prat, J; Esther, OE; Soslow, RA; Matias-Guiu, X; Palacios, J

Molecular genetic heterogeneity in undifferentiated endometrial carcinomas

Modern Pathology 29 1390-1398. 01/11/2016.

[doi:10.1038/modpathol.2016.132]

Jonsson, M; Ragnum, HB; Julin, CH; Yeramian, A; Clancy, T; Frikstad, KAM; Seierstad, T; Stokke, T; Matias-Guiu, X; Ree, AH; Flatmark, K; Lyng, H

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

BRITISH JOURNAL OF CANCER 115 929-939. 11/10/2016.

[doi:10.1038/bjc.2016.278]

Moran, S; Martinez-Cardus, A; Sayols, S; Musulen, E; Balañá C; Estival-Gonzalez, A; Moutinho, C; Heyn, H; Diaz-Lagares, A; de Moura, MC; Stella, GM; Comoglio, PM; Ruiz-Miro, M; Matias-Guiu, X; Pazo-Cid, R; Anton, A; Lopez-Lopez, R; Soler, G; Longo, F; Guerra, I; Fernandez, S; Assenov, Y; Plass, C; Morales, R; Carles, J; Bowtell, D; Mileshkin, L; Sia, D; Tothill, R; Tabernero, J; Llovet, JM; Esteller, M

Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

LANCET ONCOLOGY 17 1386-1395. 01/10/2016.

[doi:10.1016/S1470-2045(16)30297-2]